Title : Targeted therapeutic approach for an anaplastic thyroid cancer in vitro and in vivo.

Pub. Date : 2008 Sep

PMID : 18616678






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Preclinical investigations have shown antitumor activity and effectiveness of the BRAF kinase inhibitor Sorafenib and the proteasome inhibitor Bortezomib. Sorafenib B-Raf proto-oncogene, serine/threonine kinase Homo sapiens